Boehringer Ingelheim’s Post

View organization page for Boehringer Ingelheim, graphic

1,829,087 followers

#NEWS: Our first-in-class SIRPα immuno-oncology program, initiated by OSE Immunotherapeutics, is moving to the next phase in clinical development. Based on the positive data from our first clinical studies and the switch to an improved antibody we aim to provide innovative immuno-oncology treatments to the benefit of more people. Learn more: https://bit.ly/4cHPzd8 #Cancer #ImmunoOncology #ResearchAndDevelopment

  • No alternative text description for this image
Jonathon Sedgwick

Senior Vice President and Global Head Discovery Research at AbbVie

1mo

Pleased to see this MOA continuing to be tested by directly blocking the inhibitory receptor. All good luck with future studies.

Tim Zheng

Chief Scientific Officer

1mo

Congrats to BI and OSE teams on this exciting news! As a big believer in immune modulatory pathways validated by viral mimicry, I am very pleased to see this program moving forward. Best of luck with the next phase of this program!

Exciting news! Looking forward to the advancements in immuno-oncology with OSE Immunotherapeutics' SIRPα program moving to the next phase. Promising innovation for cancer treatment! #Cancer #ImmunoOncology #ResearchAndDevelopment

Great news Boehringer Ingelheim - all the best to make it accessible to everyone soon!

yun ma

Expert Clinical Data Scientist at Boehringer Ingelheim

4w

Excited to see our first-in-class SIRPα immuno-oncology program is one step closer to help patients in need!

Like
Reply
Esther Yang

HR Expert | Leadership | Inspiration | Motivation

1mo

Exciting news & times to come to make it accessible to everyone soon!

Emilio Erazo-Fischer

Director Global Business Development & Licensing Oncology bei Boehringer Ingelheim

1mo

Great to see that our partnership with OSE Immunotherapeutics is harvesting successes! Nicolas Poirier Alexis PEYROLES Scott DeWire Oliver Kast Jonathon Sedgwick Ioannis Sapountzis hope to celebrate one day altogether if this therapy makes it to cancer patients!

Tayo DAVIES, MBBS, BCMAS

| 🆂🅲🅸🅴🅽🅲🅴 🅸🅽 🅰 🆂🆄🅸🆃 | Physician in Pharma | Digital Health | I help non-medics unlock effective partnerships with physicians boosting collaboration score by 35% | AI |

1mo
Like
Reply
See more comments

To view or add a comment, sign in

Explore topics